EUVIMEDEUVIMED entdecken
Crossref

Effects of combined nutritional interventions on the natural history of X‐linked adrenoleukodystrophy in female carriers

Davide Ferrari iD, Maria Rita Spreghini, Graziamaria Ubertini, Enrico Silvio Bertini iD, Chiara Aiello, Maurizio Petrarca, Antonio Petrucci iD, Cristiano Rizzo iD, Andrea M Isidori iD, Marco Cappa iD

Journal of Neuroendocrinology · 2026

DOI: 10.1111/jne.70270 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuroendocrinology, 2026. Verfasst von Davide Ferrari und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Adrenoleukodystrophy, Triolein, Erucic Acids. Die Arbeit nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Female carriers of X‐linked adrenoleukodystrophy (X‐ALD) frequently develop neurodegenerative phenotypes resembling adrenomyeloneuropathy. However, evidence supporting disease‐modifying nutritional strategies remains limited. We evaluated the effects of Aldixyl®, a derivative of Lorenzo's Oil, and dietary interventions on neurological progression, very‐long‐chain fatty acids (VLCFAs) levels, adrenal function, and systemic safety in X‐ALD women. We conducted a single‐center retrospective longitudinal study including ABCD1 heterozygous women followed at Bambino Gesù Children's Hospital between 2001 and 2025. Neurological disability was measured by Adult ALD Clinical Score (AACS), Expanded Disability Status Scale (EDSS), and Timed 25‐Foot Walk (T25‐FW). Outcomes were compared between patients treated with Aldixyl® plus dietary prescriptions (group A) and those receiving diet‐only (group B). Thirty‐six patients were included (mean age 41.6 years), 36.1% were neurologically symptomatic at baseline (mean AACS 2.7 ± 2.6). Median C26:0 levels were mildly elevated (1.59 μmol/L). Group A ( n = 20) was older and more neurologically impaired at baseline than group B ( n = 16) (AACS 3.45 vs. 0.38). Over a median follow‐up of 69 months, neurological progression was significantly slower in group A according to AACS (LS mean difference −2.26) and EDSS (−1.03), while T25‐FW did not change. Aldixyl® exposure was associated with sustained VLCFA reduction ( β = −0.40 μmol/L). Adrenal function and metabolic parameters remained stable, although a mild, uncomplicated decrease in platelet count was observed. In female X‐ALD carriers, Aldixyl® is associated with sustained VLCFA reduction and signals suggestive of a more favorable neurological trajectory, while preserving adrenal function and demonstrating an acceptable safety profile. These findings warrant confirmation in prospective, controlled studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdrenoleukodystrophyTrioleinErucic AcidsHumansFemaleRetrospective StudiesAdultLongitudinal StudiesHeterozygoteATP Binding Cassette Transporter, Subfamily D, Member 1Middle AgedDisease ProgressionDrug Combinations

Stichwörter der Autor:innen

Aldixyl®Lorenzo's oilX‐ALDadrenoleukodystrophynutritional interventions

Substanzen

Lorenzo's oilTrioleinATP Binding Cassette Transporter, Subfamily D, Member 1Erucic AcidsABCD1 protein, humanDrug Combinations

Autor:innen und Institutionen

  • Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
  • Endocrinology and Diabetology Unit', Bambino Gesù' Children's Hospital, IRCCS, Rome, Italy.
  • Unit of Neuromuscular and Neurodegenerative Disorders, Department of Neurosciences, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
  • Laboratory of Medical Genetics, Translational Cytogenomics Research Unit, IRCCS Bambino Gesù Children Hospital, IRCCS, Rome, Italy.
  • Movement Analysis and Robotics Laboratory, "Bambino Gesù" Children's Hospital-IRCCS, Rome, Italy.
  • Center for Neuromuscular and Neurological Rare Diseases, S. Camillo Forlanini Hospital, Rome, Italy.

ORCID-Profile: Davide Ferrari, Enrico Silvio Bertini, Antonio Petrucci, Cristiano Rizzo, Andrea M Isidori, Marco Cappa

Zitieren

APA

Ferrari, D., Spreghini, M. R., Ubertini, G., Bertini, E. S., Aiello, C., Petrarca, M., Petrucci, A., Rizzo, C., Isidori, A. M., & Cappa, M. (2026). Effects of combined nutritional interventions on the natural history of X‐linked adrenoleukodystrophy in female carriers. Journal of Neuroendocrinology. https://doi.org/10.1111/jne.70270

Vancouver

Ferrari D, Spreghini MR, Ubertini G, Bertini ES, Aiello C, Petrarca M, et al. Effects of combined nutritional interventions on the natural history of X‐linked adrenoleukodystrophy in female carriers. Journal of Neuroendocrinology. 2026. doi:10.1111/jne.70270

BibTeX
@article{Ferrari2026,
  author = {Ferrari, Davide and Spreghini, Maria Rita and Ubertini, Graziamaria and Bertini, Enrico Silvio and Aiello, Chiara and Petrarca, Maurizio and Petrucci, Antonio and Rizzo, Cristiano and Isidori, Andrea M and Cappa, Marco},
  title = {Effects of combined nutritional interventions on the natural history of X‐linked adrenoleukodystrophy in female carriers},
  journal = {Journal of Neuroendocrinology},
  year = {2026},
  doi = {10.1111/jne.70270}
}
Kostenlos starten →